Search tips
Search criteria 


Logo of bmjcredLink to Publisher's site
Br Med J (Clin Res Ed). 1986 November 8; 293(6556): 1195–1199.
PMCID: PMC1341978

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.


Forty five insulin dependent diabetics were randomised to treatment with continuous subcutaneous insulin infusion (CSII), multiple insulin injections (five or six daily), or conventional twice daily insulin injections. Near normoglycaemia was obtained with CSII and multiple injections but not with conventional treatment (p less than 0.01). Hypoglycaemic coma was observed less frequently with CSII than with multiple injections and conventional treatment (p less than 0.001), but blood glucose concentrations below 2.5 mmol/l (45 mg/100 ml) were more common. After two years fewer retinal microaneurysms and haemorrhages had developed in the patients given CSII and multiple injections compared with those given conventional treatment, in whom the number had increased significantly (p less than 0.01). Motor nerve conduction velocity deteriorated in the patients given conventional treatment; in those given CSII it was unchanged during the first year but had improved after two years (p less than 0.01). Glomerular hyperfiltration was reduced with CSII, but no change occurred in urine albumin excretion rates. Long term near normoglycaemia may prevent the progression of early stages of late diabetic complications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mauer SM, Steffes MW, Sutherland DE, Najarian-S, Michael AF, Brown DM. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes. 1975 Mar;24(3):280–285. [PubMed]
  • Engerman R, Bloodworth JM, Jr, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes. 1977 Aug;26(8):760–769. [PubMed]
  • JOHNSSON S. Retinopathy and nephropathy in diabetes mellitus: comparison of the effects of two forms of treatment. Diabetes. 1960 Jan-Feb;9:1–8. [PubMed]
  • Keen H. Normoglycaemic re-entry and diabetic complications. Diabet Med. 1984 Jul;1(2):85–87. [PubMed]
  • Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983 Jan 29;1(8318):200–204. [PubMed]
  • Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):811–815. [PMC free article] [PubMed]
  • Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L. Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol. 1985 Nov 15;100(5):644–653. [PubMed]
  • Dahl-Jørgensen K, Larsen AE. HbA1 determination by agar gel electrophoresis after elimination of labile HbA1: a comparison with ion-exchange chromatography. Scand J Clin Lab Invest. 1982 Feb;42(1):27–33. [PubMed]
  • Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972 Nov;30(3):271–274. [PubMed]
  • Eschwege E, Job D, Guyot-Argenton C, Aubry JP, Tchobroutsky G. Delayed progression of diabetic retinopathy by divided insulin administration: a further follow-up. Diabetologia. 1979 Jan;16(1):13–15. [PubMed]
  • Kohner EM, Lawson PM, Ghosh G, Testa M. Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Assessment of fluorescein angiograms. Diabetes. 1985 Aug;34 (Suppl 3):56–60. [PubMed]
  • Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, et al. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med. 1983 Jan 20;308(3):119–125. [PubMed]
  • Boulton AJ, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care. 1982 Jul-Aug;5(4):386–390. [PubMed]
  • Hamet P, Abarca G, Lopez D, Hamet M, Bourque M, Peyronnard JM, Charron L, Larochelle P. Patient self-management of continuous subcutaneous insulin infusion. Diabetes Care. 1982 Sep-Oct;5(5):485–491. [PubMed]
  • Gambardella S, Napoli A, Spallone V, Verrastro AM, Lazzari R, Geraldini C, Sideri G, Menzinger G. Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics. J Endocrinol Invest. 1983 Oct;6(5):363–367. [PubMed]
  • Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia. 1985 Oct;28(10):722–727. [PubMed]
  • Mogensen CE. Glomerular filtration rate and renal plasma flow in long-term juvenile diabetics without proteinuria. Br Med J. 1972 Nov 4;4(5835):257–259. [PMC free article] [PubMed]
  • Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982 Mar;72(3):375–380. [PubMed]
  • Friedman EA. Diabetic nephropathy: strategies in prevention and management. Kidney Int. 1982 May;21(5):780–791. [PubMed]
  • Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. [PubMed]
  • Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med. 1985 Mar 7;312(10):617–621. [PubMed]
  • Skyler JS, Seigler DE, Reeves ML. A comparison of insulin regimens in insulin-dependent diabetes mellitus. Diabetes Care. 1982 May-Jun;5 (Suppl 1):11–18. [PubMed]
  • Home PD, Capaldo B, Burrin JM, Worth R, Alberti KG. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care. 1982 Sep-Oct;5(5):466–471. [PubMed]
  • Schiffrin A, Belmonte MM. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study. Diabetes. 1982 Mar;31(3):255–264. [PubMed]
  • Mecklenburg RS, Benson EA, Benson JW, Jr, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sanner CA. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA. 1984 Dec 21;252(23):3265–3269. [PubMed]
  • Home PD, Marshall SM. Problems and safety of continuous subcutaneous insulin infusion. Diabet Med. 1984 May;1(1):41–44. [PubMed]
  • Ward JD. Continuous subcutaneous insulin infusion (CSII): therapeutic options. Diabet Med. 1984 May;1(1):47–50. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group